When we analyzed these data with respect to the estimated presence of S100B in the diet, the meta-regression revealed a significant negative association between S100B concentration and normalized relative risk of Crohn’s disease (β = –0.0356, p < 0.001), suggesting that higher S100B levels are linked to lower disease risk (Figure 3B). Here, S100B is linked to Crohn disease.